Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950144-02-004639
Filing Date
2002-05-01
Accepted
2002-05-01 17:09:06
Documents
3
Period of Report
2002-03-30

Document Format Files

Seq Description Document Type Size
1 NABI BIOPHARMACEUTICALS FORM 10-Q 3-30-2002 g75942e10-q.htm 10-Q 171785
3 CHANGE IN CONTROL: THOMAS H. MCLAIN g75942ex10-49.txt EX-10.49 25436
4 CHANGE IN CONTROL: MARK L. SMITH g75942ex10-50.txt EX-10.50 25427
  Complete submission text file 0000950144-02-004639.txt   224663
Mailing Address P.O. BOX 310701 P O BOX 692222 BOCA RATON FL 33431
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: 10-Q | Act: 34 | File No.: 000-04829 | Film No.: 02630551
SIC: 2836 Biological Products, (No Diagnostic Substances)